All posts tagged "Bharat Biotech"
-
213NEWSBharat Biotech stresses on Covaxin’s safety record after AstraZeneca admits to Covishield causing rare clotting side effects
HYDERABAD: After AstraZeneca’s admitted in a UK court that its Covid-19 vaccine caused a rare side-effect — Thrombosis with Thrombocytopenia Syndrome (TTS),...
-
273NEWSOver 7,000 Doses of Bharat Biotech’s Intranasal Covid Jab Ready for Market Rollout as Apex Lab Clears First Batch
The painless, non-invasive and needleless vaccine was officially launched by the Union Health Ministry on Republic Day but is yet to be...
-
361NEWSIndia’s Own Needle-free Nasal Covid-19 Vaccine Launched As Booster for Adults
In December, Hyderabad-based company Bharat Biotech announced that it would sell the intranasal vaccine for Rs 325 per shot for procurement by...
-
258NEWSBharat Biotech to launch its intranasal Covid vaccine likely on Jan 26
Bhopal: The nasal Covid-19 vaccine from Bharat Biotech, known as the iNCOVACC, is anticipated to be on sale on January 26. Executive...
-
434NEWSBharat Biotech’s nasal vaccine to cost around Rs 800: Sources
Asingle dose of Bharat Biotech’s intranasal vaccine iNCOVACC, which was approved for inclusion into India’s Covid-19 immunisation programme last week, will cost...
-
433HEALTHBharat Biotech’s Nasal Vaccine Rolls Out Today Amid Covid BF.7 Scare. How & Where to Get | FAQ
Amid a sharp uptick in demand for the precautionary vaccine dose in the country since last week, the Union Health Ministry has approved Bharat...
-
405NEWS
Bharat Biotech urges Centre to include intranasal Covid vaccine in CoWIN portal
Bharat Biotech has requested the central government to include its intranasal COVID-19 vaccine iNCOVACC, in CoWIN portal to enable the recipients of the jab to...
-
464HEALTH
World’s 1st Intranasal Covid vax from Bharat Biotech gets CDSCO approval
Hyderabad: Leading vaccine maker, Bharat Biotech International Limited (BBIL) on Monday announced that world’s first intranasal vaccine for Covid-19, iNCOVACC (BBV154), has...
-
393NEWS
Bharat Biotech’s Intranasal Covid-19 Booster Gets DCGI Approval for Emergency Use Authorisation
The booster dose of Bharat Biotech’s Covid-19 nasal vaccine iNCOVACC on Friday received emergency use authorisation (EUA) from the Drugs Controller General...
-
370NEWSBharat Biotech gets emergency use authorisation for intranasal COVID-19 vaccine
Bharat Biotech International Ltd (BBIL) on Tuesday got emergency use authorisation from DCGI for intranasal COVID-19 vaccine, announced Union Health Minister Mansukh...
